OPKO Health (OPK) Tops Q4 EPS by 9c
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.49 -3.25%
EPS Growth %: -333.3%
Financial Fact:
Research and development: 24.42M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -333.3%
Financial Fact:
Research and development: 24.42M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q4 EPS of $0.01, $0.09 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $103.1 million versus the consensus estimate of $156.35 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Microsoft plans data center push to triple its computing power - Bloomberg
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- Edwards Lifesciences responds to CMS TAVR coverage decision
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
